[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[2] 邵一鸣,苏力德,郝睿,等.乙型肝炎病毒诱发肝细胞癌分子机制研究进展 [J].浙江大学学报:医学版,2021,50(1):113-122.
SHAO YM,SU LD,HAO R,et al.Advances on molecular mechanism of hepatitis B virus induced hepatocellular carcinoma [J].Journal of Zhejiang University(Medical Sciences),2021,50(1):113-122.
[3] BAECKER A,LIU X,LA VECCHIA C,et al.Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors [J].Eur J Cancer Prev,2018,27(3):205-212.
[4] LURJE I,CZIGANY Z,BEDNARSCH J,et al.Treatment strategies for hepatocellular carcinoma-a multidisciplinary approach [J].Int J Mol Sci,2019,20(6):1465.
[5] LEE JK,ABOU-ALFA GK.An update on clinical trials in the treatment of advanced hepatocellular carcinoma [J].J Clin Gastroenterol,2013,47 Suppl:S16-19.
[6] AHMED SBM,PRIGENT SA.Insights into the shc family of adaptor proteins [J].J Mol Signal,2017,12:2.
[7] XU N,WU YP,YIN HB,et al.SHCBP1 promotes tumor cell proliferation,migration,and invasion,and is associated with poor prostate cancer prognosis [J].J Cancer Res Clin Oncol,2020,146(8):1953-1969.
[8] DONG YD,YUAN YL,YU HB,et al.SHCBP1 is a novel target and exhibits tumor-promoting effects in gastric cancer [J].Oncol Rep,2019,41(3):1649-1657.
[9] FENG W,LI HC,XU K,et al.SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line [J].Gene,2016,587(1):91-97.
[10] PENG C,ZHAO H,SONG Y,et al.SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/smad signaling pathway and is associated with poor prognosis [J].J Exp Clin Cancer Res,2017,36(1):141.
[11]陶汉川,王珵,赵晶晶,等.SHCBP1基因在结肠癌组织中表达及对结肠癌细胞增殖迁移的影响[J].现代肿瘤医学,2019,27(13):2244-2249.
TAO HC,WANG C,ZHAO JJ,et al.Expression of SHCBP1 in colon cancer tissues and its effect on proliferation and migration of human colon cancer cell line[J].Modern Oncology,2019,27(13):2244-2249.
[12] WANG N,ZHU L,WANG L,et al.Identification of SHCBP1 as a potential biomarker involving diagnosis,prognosis,and tumor immune microenvironment across multiple cancers [J].Comput Struct Biotechnol J,2022,20:3106-3119.
[13] LONG J,BAI Y,YANG X,et al.Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma [J].Cancer Cell Int,2019,19:90.
[14] TAO HC,WANG HX,DAI M,et al.Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells [J].Asian Pac J Cancer Prev,2013,14(10):5645-5650.
[15] VALE RD,REESE TS,SHEETZ MP.Identification of a novel force-generating protein,kinesin,involved in microtubule-based motility [J].Cell,1985,42(1):39-50.
[16] VICENTE JJ,WORDEMAN L.Mitosis,microtubule dynamics and the evolution of kinesins [J].Exp Cell Res,2015,334(1):61-69.
[17] QIAN LX,CAO X,DU MY,et al.KIF18A knockdown reduces proliferation,migration,invasion and enhances radiosensitivity of esophageal cancer [J].Biochem Biophys Res Commun,2021,557:192-198.
[18] ZHANG H,SHEN T,ZHANG Z,et al.Expression of KIF18A is associated with increased tumor stage and cell proliferation in prostate cancer [J].Med Sci Monit,2019,25:6418-6428.
[19] ZHONG Y,JIANG L,LIN H,et al.Overexpression of KIF18A promotes cell proliferation,inhibits apoptosis,and independently predicts unfavorable prognosis in lung adenocarcinoma [J].IUBMB Life,2019,71(7):942-955.
[20] LUO W,LIAO M,LIAO Y,et al.The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma [J].World J Surg Oncol,2018,16(1):36.
[21] LEE TK,GUAN XY,MA S.Cancer stem cells in hepatocellular carcinoma-from origin to clinical implications [J].Nat Rev Gastroenterol Hepatol,2022,19(1):26-44.
[22] LIU YC,YEH CT,LIN KH.Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies [J].Cells,2020,9(6):1331.
[23] NAKAMURA M,CHIBA T,KANAYAMA K,et al.Epigenetic dysregulation in hepatocellular carcinoma:An up-to-date review [J].Hepatol Res,2019,49(1):3-13.
[24] GENG H,GUO M,XU W,et al.SHCBP1 promotes papillary thyroid carcinoma carcinogenesis and progression through promoting formation of integrin and collagen and maintaining cell stemness [J].Front Endocrinol(Lausanne),2020,11:613879.
[25] SEO S,JEON HY,KIM H.Comparison of cellular transforming activity of OCT4,NANOG,and SOX2 in immortalized astrocytes [J].DNA Cell Biol,2017,36(11):1000-1009.
[26] 王寒琪,王晋星一,陈林,等.不同迁移能力肝癌细胞中干细胞相关基因Nanog、Sox2和Oct4的表达 [J].贵阳医学院学报,2013,38(3):226-230.
WANG HQ,WANG JXY,CHEN L,et al.Expression of stem cell related genes Nanog,Sox2 and Oct4 in liver cancer cells with different migration abilities [J].Journal of Guiyang Medical College,2013,38(3):226-230.
[27] LIU L,YANG Y,LIU S,et al.EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression [J].Oncogene,2019,38(5):747-764.
[28] 王立,杨松,孙若川,等.驱动蛋白超家族18A在胃癌组织中的表达及其与患者预后的关系 [J].中华胃肠外科杂志,2016,19(5):585-589.
WANG L,YANG S,SUN RC,et al.Expression of KIF18A in gastric cancer and its association with prognosis [J].Chinese Journal of Gastrointestinal Surgery,2016,19(5):585-589.
[29] SABNIS RW.Novel KIF18A inhibitors for treating cancer [J].ACS Med Chem Lett,2020,11(12):2368-2369.
[30] LIAO W,HUANG G,LIAO Y,et al.High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma [J].Oncotarget,2014,5(21):10271-10279.
[31] YANG J,ZHANG Q,YANG Z,et al.KIF18A interacts with ppp1ca to promote the malignant development of glioblastoma [J].Exp Ther Med,2023,25(4):154.
[32] FENG G,XUE F,HE Y,et al.The identification of stemness-related genes in the risk of head and neck squamous cell carcinoma [J].Front Oncol,2021,11:688545.